To further reveal the mechanism(s) of action of the two structurally different RAF inhibitors, we performed a gene expression analysis of CLL cells co-cultured on HS5-CD40L-IL4-IL21 in the pan-RAF inhibitors’ presence or absence. The gene discussed is IL21; the disease is B-cell chronic lymphocytic leukemia.